Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.

Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.

Item
http://www.wikidata.org/entity/Q38746537
Computationally Informed Design of a Multi-Axial Actuated Microfluidic Chip Device.Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors.Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis.Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells.Organs on chip approach: a tool to evaluate cancer -immune cells interactions.Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade.Anti-IL-10-mediated Enhancement of Antitumor Efficacy of a Dendritic Cell-targeting MIP3α-gp100 Vaccine in the B16F10 Mouse Melanoma Model Is Dependent on Type I Interferons.Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression.
P2860

Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.

Item
http://www.wikidata.org/entity/Q38746537
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Combining Type I Interferons a ...... mor Response against Melanoma.
@en
type
label
Combining Type I Interferons a ...... mor Response against Melanoma.
@en
prefLabel
Combining Type I Interferons a ...... mor Response against Melanoma.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Combining Type I Interferons a ...... mor Response against Melanoma.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698